Behind the nutraceuticals boom in India
Impressive profit margins are driving more startups to sell these supplements, but they have to face fickle consumer habits and compete with pharma giants.

Why read this story?
Editor's note: When Sudheer Makam returned to India in 2015 after a decade of working in the nutraceuticals business in Singapore, he noticed Indians were warming to dietary supplements, but were reluctant to use them regularly. He spent the next five years trying to understand consumer behaviour. It all changed in 2020. With the COVID-19 pandemic, an increasing number of people took to multivitamins, hoping to build immunity against the virus. For Makam, it was a perfect business opportunity. He partnered with a friend, who has a drug manufacturing facility in Hyderabad, to build a startup that today sells over 300 vitamin packs a month. Founded in December 2020, Vitamins & Me customizes immunity-boosting products according to consumers’ health needs. Makam’s is among the several nutraceutical startups that have sprung up in the past two years. According to startup research firm Tracxn, of the top 50 startups in the nutraceuticals space, 20 received funding in the past three years alone—including from the likes of Sequoia Capital, Fireside Ventures, Sixth Sense Ventures and Chiratae Ventures. Nutraceuticals, which combine “nutrition” and “pharmaceuticals”, refer to …
More in Internet
You may also like
How HealthKart pulled off a D2C pivot to success and profits
In a winner-take-all market, horizontal e-commerce companies should have decimated HealthKart’s reason to exist. In a remarkable turn of events, not only has the company persisted but it is also growing and profitable.
Eternal, Swiggy, Zepto are all unskilled worker arbitrage businesses
Exploitation of unskilled workers is at the heart of quick-delivery service businesses in India. They should be valued for what they are and not what they pretend to be, a trait that has taken a devious form of wanting it both ways.
Indian consumer startups end 2025 on a high. Next year may not be so easy.
Stories of great outcomes and easy funding kept the sector on its toes. The momentum is expected to continue going into 2026, but startups may need to rethink their strategy.






